![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HIV Combinectin BMS-986197: A long-acting inhibitor with multiple modes of action
|
|
|
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Mark Krystal, David Wensel, Yongnian Sun, Jonathan Davis, Zhufang Li, Thomas McDonagh, Sharon Zhang, Matt Soars, Mark Cockett
Bristol-Myers Squibb, Research and Development, Wallingford, CT and Waltham, MA
WEBCAST link: http://www.croiwebcasts.org/console/player/29623?mediaType=audio&
![CROI1](../images/022916/022916-7/CROI1.gif)
![CROI2](../images/022916/022916-7/CROI2.gif)
![CROI3](../images/022916/022916-7/CROI3.gif)
![CROI4](../images/022916/022916-7/CROI4.gif)
![CROI5](../images/022916/022916-7/CROI5.gif)
![CROI6](../images/022916/022916-7/CROI6.gif)
![CROI7](../images/022916/022916-7/CROI7.gif)
![CROI8](../images/022916/022916-7/CROI8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|